Genelux (GNLX) Corporation announced that it has commenced a proposed underwritten public offering of its common stock. All shares are being offered by Genelux. Lucid Capital Markets is acting as the sole book-running manager for the proposed offering.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GNLX:
- Genelux data update indicates disease early control, says H.C. Wainwright
- Maintaining Buy on Genelux: Early Olvi-Vec Data Signal Differentiated Potential in Relapsed/Refractory Lung Cancer
- Genelux Reports Encouraging Interim Data for Olvi-Vec Trials
- Genelux reports interim data of systemic administration of Olvi-Vec
- Genelux Appoints Veteran Oncologist Jason Litten as CMO